Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Protagonist Therapeutics Inc (PTGX)

Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Protagonist Therapeutics: Q4 Earnings Snapshot

Protagonist Therapeutics: Q4 Earnings Snapshot

PTGX : 28.48 (+1.71%)
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On

Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.

NVS : 95.88 (+0.64%)
JNJ : 157.96 (+1.41%)
LEGN : 56.93 (+1.84%)
CVRX : 17.99 (-0.28%)
PTGX : 28.48 (+1.71%)
Protagonist Therapeutics: Q3 Earnings Snapshot

Protagonist Therapeutics: Q3 Earnings Snapshot

PTGX : 28.48 (+1.71%)
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 22, 2023 – USA News Group  –  Despite the potential federal funding challenges due to the recent debt ceiling...

RY : 100.40 (+1.26%)
RY.TO : 136.23 (+1.12%)
ONCY : 1.0300 (+1.98%)
ONC.TO : 1.38 (unch)
JAZZ : 120.51 (+2.19%)
ZYME : 10.30 (-1.62%)
AMGN : 286.30 (+1.61%)
PTGX : 28.48 (+1.71%)
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

/PRNewswire/ -- USA News Group - Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer...

ONC.TO : 1.38 (unch)
ONCY : 1.0300 (+1.98%)
ZYME : 10.30 (-1.62%)
JAZZ : 120.51 (+2.19%)
PTGX : 28.48 (+1.71%)
AMGN : 286.30 (+1.61%)
Pioneering Cancer Treatments Show Promising Progress Despite Fiscal Challenges

USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer persists, thanks in large part to the audacious “Cancer...

RY : 100.40 (+1.26%)
RY.TO : 136.23 (+1.12%)
ONCY : 1.0300 (+1.98%)
ONC.TO : 1.38 (unch)
JAZZ : 120.51 (+2.19%)
ZYME : 10.30 (-1.62%)
AMGN : 286.30 (+1.61%)
PTGX : 28.48 (+1.71%)
Protagonist Therapeutics: Q2 Earnings Snapshot

Protagonist Therapeutics: Q2 Earnings Snapshot

PTGX : 28.48 (+1.71%)
Are (More) Big Gains Ahead for This Small Cap Biotech Stock?

With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.

BMEA : 15.36 (+2.74%)
SPPI : 1.0300 (unch)
PTGX : 28.48 (+1.71%)
Chart of the Day: Protagonist Therapeutics - Wide Opinions

The Chart of the Day belongs to the biopharmaceutical company Protagonist Therapeutics (PTGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical...

PTGX : 28.48 (+1.71%)
Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113

/PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") reported data from its collaboration with Janssen Biotech, Inc., one...

PTGX : 28.48 (+1.71%)

Barchart Exclusives

IonQ vs. D-Wave: Which Quantum Computing Stock Has More Upside Potential?
In the growing quantum computing market, analysts expect IONQ stock to deliver significantly higher upside than QBTS. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar